SCHEMBL21755831

SCHEMBL21755831

CNc1cccc(COc2cnc(OC)cc2C=O)c1C=N

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
ERN1 O75460 3/20 0.33
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPC1 O15118 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
RAF1 P04049 2/20 0.32
BRAF P15056 2/20 0.32
PDE10A Q9Y233 1/20 0.31
TLR2 O60603 1/20 0.30
TLR1 Q15399 1/20 0.30
TLR6 Q9Y2C9 1/20 0.30
PDCD1 Q15116 1/20 0.30
CD274 Q9NZQ7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21755840 0.85 ALDH1A1 (0.34) ALDH1A1ERN1MAPTSMN1; SMN2NPC1
SCHEMBL18630392 0.83 RAB9A (0.43) ALDH1A1ERN1MAPTSMN1; SMN2NPC1
SCHEMBL15088077 0.77 ALDH1A1 (0.39) ALDH1A1ERN1MAPTSMN1; SMN2NPC1
SCHEMBL30078009 0.77 ALDH1A1 (0.39) ALDH1A1ERN1MAPTSMN1; SMN2NPC1
SCHEMBL21755841 0.75 ERN1 (0.32) ALDH1A1ERN1MAPTSMN1; SMN2NPC1
SCHEMBL15065865 0.74 ERN1 (0.47) ALDH1A1ERN1MAPTSMN1; SMN2NPC1
SCHEMBL30078010 0.73 TRIM24 (0.42) ALDH1A1ERN1MAPTSMN1; SMN2NPC1
SCHEMBL15066133 0.73 TRIM24 (0.42) ALDH1A1ERN1MAPTSMN1; SMN2NPC1
SCHEMBL21755834 0.73 ERN1 (0.32) ALDH1A1ERN1MAPTSMN1; SMN2NPC1
SCHEMBL21755837 0.73 PTGDR2 (0.34) ALDH1A1MAPTSMN1; SMN2NPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797597-B1 SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION GLOBAL BLOOD THERAPEUTICS INC (US) 2020-02-26 EP disclosed